These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18504132)

  • 21. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production.
    Van Camp JA; Hu LY; Kostlan C; Lefker B; Li J; Mitchell L; Wang Z; Yue WS; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5529-32. PubMed ID: 17764935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists.
    Jain N; Allan G; Linton O; Tannenbaum P; Chen X; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Murray W; Sui Z
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3977-80. PubMed ID: 19217285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.
    Hamann LG; Farmer LJ; Johnson MG; Bender SL; Mais DE; Wang MW; Crombie D; Goldman ME; Jones TK
    J Med Chem; 1996 Apr; 39(9):1778-89. PubMed ID: 8627601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.
    Sakai H; Hirano T; Mori S; Fujii S; Masuno H; Kinoshita M; Kagechika H; Tanatani A
    J Med Chem; 2011 Oct; 54(20):7055-65. PubMed ID: 21916484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-(4-Chlorophenyl)-5,6-dihydro-1,3-oxazepin-7(4H)-one derivatives as lipophilic cyclic analogues of baclofen: design, synthesis, and neuropharmacological evaluation.
    Abdel-Hafez AA; Abdel-Wahab BA
    Bioorg Med Chem; 2008 Sep; 16(17):7983-91. PubMed ID: 18693017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
    Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity.
    Dow RL; Carpino PA; Hadcock JR; Black SC; Iredale PA; DaSilva-Jardine P; Schneider SR; Paight ES; Griffith DA; Scott DO; O'Connor RE; Nduaka CI
    J Med Chem; 2009 May; 52(9):2652-5. PubMed ID: 19351113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.
    Zhi L; Tegley CM; Marschke KB; Mais DE; Jones TK
    J Med Chem; 1999 Apr; 42(8):1466-72. PubMed ID: 10212133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new generation of progesterone receptor modulators.
    Winneker RC; Fensome A; Zhang P; Yudt MR; McComas CC; Unwalla RJ
    Steroids; 2008 Aug; 73(7):689-701. PubMed ID: 18472121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzo- and pyrido-1,4-oxazepin-5-ones and -thiones: synthesis and structure-activity relationships of a new series of H1 antihistamines.
    Cale AD; Gero TW; Walker KR; Lo YS; Welstead WJ; Jaques LW; Johnson AF; Leonard CA; Nolan JC; Johnson DN
    J Med Chem; 1989 Sep; 32(9):2178-99. PubMed ID: 2570152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, SAR studies, and evaluation of 1,4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: Discovery of Piclozotan.
    Kamei K; Maeda N; Nomura K; Shibata M; Katsuragi-Ogino R; Koyama M; Nakajima M; Inoue T; Ohno T; Tatsuoka T
    Bioorg Med Chem; 2006 Mar; 14(6):1978-92. PubMed ID: 16290165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers.
    Qin J; Qu S; Zhu K; Cheng Y; Pan G; Jing W; Liu X; Sun X; Liu L
    Bioorg Med Chem; 2021 Feb; 32():116003. PubMed ID: 33461148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.
    Berrodin TJ; Jelinsky SA; Graciani N; Butera JA; Zhang Z; Nagpal S; Winneker RC; Yudt MR
    Biochem Pharmacol; 2009 Jan; 77(2):204-15. PubMed ID: 19013437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of some 1,3-dihydro-2H-3-benzazepin-2-ones with a piperazine moiety as bradycardic agents.
    Liang HY; Zhang DQ; Yue Y; Shi Z; Zhao SY
    Arch Pharm (Weinheim); 2010 Feb; 343(2):114-9. PubMed ID: 20108265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
    Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Zhang Z
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1313-6. PubMed ID: 12657271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives. herve.geneste@abbott.com.
    Geneste H; Backfisch G; Braje W; Delzer J; Haupt A; Hutchins CW; King LL; Lubisch W; Steiner G; Teschendorf HJ; Unger L; Wernet W
    Bioorg Med Chem Lett; 2006 Feb; 16(3):658-62. PubMed ID: 16271293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.
    Washburn DG; Hoang TH; Frazee JS; Johnson L; Hammond M; Manns S; Madauss KP; Williams SP; Duraiswami C; Tran TB; Stewart EL; Grygielko ET; Glace LE; Trizna W; Nagilla R; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4664-8. PubMed ID: 19616429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
    Zhang J; Chen X; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.